We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+12.16%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$718B
AUM Growth
+$49.7B
Cap. Flow
-$15.6B
Cap. Flow %
-2.17%
Top 10 Hldgs %
31.75%
Holding
3,044
New
123
Increased
1,636
Reduced
968
Closed
150

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.11B
2
META icon
Meta Platforms (Facebook)
META
+$2.59B
3
EQT icon
EQT Corp
EQT
+$1.31B
4
CL icon
Colgate-Palmolive
CL
+$1.08B
5
ADBE icon
Adobe
ADBE
+$1.06B

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.92B
2
UNH icon
UnitedHealth
UNH
+$1.78B
3
AMD icon
Advanced Micro Devices
AMD
+$1.55B
4
ROST icon
Ross Stores
ROST
+$1.54B
5
ASML icon
ASML
ASML
+$1.49B

Sector Composition

Rank Sector Weight
1 Technology 31.61%
2 Healthcare 16.91%
3 Consumer Discretionary 11.05%
4 Financials 10.6%
5 Communication Services 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVBG
2026
DELISTED
Everbridge, Inc. Common Stock
EVBG
$615K ﹤0.01%
22,839
+441
+2% +$11.9K
KDNY
2027
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$613K ﹤0.01%
15,944
-12,378
-44% -$318K
WIX icon
2028
WIX.com
WIX
$3.35B
$612K ﹤0.01%
7,805
-8,549
-52% -$703K
NEX
2029
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$608K ﹤0.01%
67,916
+8,624
+15% +$71.1K
INVA icon
2030
Innoviva
INVA
$1.5B
$606K ﹤0.01%
47,541
+1,243
+3% +$15.6K
WWW icon
2031
Wolverine World Wide
WWW
$1.48B
$605K ﹤0.01%
41,173
+802
+2% +$12.3K
VICR icon
2032
Vicor
VICR
$10.4B
$602K ﹤0.01%
11,143
+204
+2% +$10.1K
FFIC
2033
DELISTED
Flushing Financial
FFIC
$597K ﹤0.01%
48,543
+180
+0.4% +$2.27K
MRC
2034
DELISTED
MRC Global
MRC
$597K ﹤0.01%
59,203
+1,421
+2% +$13.4K
OXM icon
2035
Oxford Industries
OXM
$538M
$595K ﹤0.01%
6,037
+160
+3% +$16.4K
MNKD icon
2036
MannKind Corp
MNKD
$1.24B
$590K ﹤0.01%
144,871
+10,735
+8% +$44.8K
BZH icon
2037
Beazer Homes USA
BZH
$874M
$588K ﹤0.01%
20,773
+386
+2% +$7.87K
BBT
2038
Beacon Financial Corp
BBT
$2.71B
$587K ﹤0.01%
28,282
+709
+3% +$15.3K
EGBN icon
2039
Eagle Bancorp
EGBN
$877M
$584K ﹤0.01%
27,563
+2,320
+9% +$54.6K
VECO icon
2040
Veeco
VECO
$3.26B
$584K ﹤0.01%
22,738
+737
+3% +$16.2K
ZETA icon
2041
Zeta Global
ZETA
$7.44B
$583K ﹤0.01%
68,190
+23,438
+52% +$214K
BKD icon
2042
Brookdale Senior Living
BKD
$3.1B
$582K ﹤0.01%
137,848
-39,253
-22% -$152K
ADAM
2043
Adamas Trust
ADAM
$913M
$582K ﹤0.01%
58,578
+1,363
+2% +$13.5K
UVSP icon
2044
Univest Financial
UVSP
$1.18B
$582K ﹤0.01%
32,150
+4,063
+14% +$79.6K
ACCO icon
2045
Acco Brands
ACCO
$399M
$581K ﹤0.01%
111,501
+1,756
+2% +$8.83K
COLL icon
2046
Collegium Pharmaceutical
COLL
$913M
$580K ﹤0.01%
26,970
+422
+2% +$9.58K
MCBC
2047
DELISTED
Macatawa Bank Corp
MCBC
$580K ﹤0.01%
62,396
+4,325
+7% +$40.1K
GBX icon
2048
The Greenbrier Companies
GBX
$1.41B
$576K ﹤0.01%
13,350
+362
+3% +$10.7K
BRSP
2049
BrightSpire Capital
BRSP
$628M
$575K ﹤0.01%
85,413
+14,278
+20% +$84.7K
CAL icon
2050
Caleres
CAL
$455M
$574K ﹤0.01%
23,947
+412
+2% +$9.22K

Similar funds

T. Rowe Price Associates's Q2 2023 Portfolio in Review

As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
  • T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
  • T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
  • T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
  • T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
  • T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.